Leading prescription drug product was coming off patent. The product was also being reformulated.
Developed a free starter supply program targeting physicians and pharmacies to drive patient conversions to the new therapy. This was supported by a co-pay offset program significantly minimizing patient out-of-pocket cost challenges and driving compliance.
paid claims per month (approx.)
in payments per month (approx.)
- Weekly and monthly customized brand reports
- Ad-hoc reports as required
Successful conversion of patients to the new formulation, resulting in positive program ROI.